Juul M. Van Den Reek
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Population Pharmacokinetic-Pharmacodynamic Model for Secukinumab in Psoriasis Patients.
Journal: The Journal of investigative dermatology
Published: March 31, 2026
Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER): Protocol for a Longitudinal Observational Study.
Journal: JMIR research protocols
Published: June 30, 2021
Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on Ustekinumab.
Journal: Therapeutic drug monitoring
Published: May 21, 2019
Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs.
Journal: Acta dermato-venereologica
Published: February 21, 2017
Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients.
Journal: The British journal of dermatology
Published: February 13, 2017
Determinants for drug survival of methotrexate in patients with psoriasis, split according to different reasons for discontinuation: results of the prospective MTX-CAPTURE.
Journal: The British journal of dermatology
Published: January 01, 2017
Drug Survival and Predictors of Drug Survival for Methotrexate Treatment in a Retrospective Cohort of Adult Patients with Localized Scleroderma.
Journal: Acta dermato-venereologica
Published: March 18, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026